The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...

Treating ADHD is straightforward with stimulants, often giving patients life-changing relief. But with comorbid conditions, ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...